Monitor execution of cost reduction initiatives and medical cost trend management in 2026. The significant improvement in guidance suggests potential turnaround, but investors should watch for actual execution against these ambitious targets.
Price Chart
Executive Summary
Agilon Health reported a decline in financial performance for fiscal year 2025, with revenue down 2%, gross loss of $160M, and Adjusted EBITDA loss of $296M. However, the company issued 2026 guidance projecting a return to breakeven Adjusted EBITDA, driven by improved rates, cost discipline, and portfolio optimization. This combination of poor results with optimistic forward guidance creates a mixed outlook.
Key Financial Metrics
Key Facts
- 2025 revenue decreased 2% YoY to $5.93B
- Gross loss was $160M in 2025 vs. $5M profit in 2024
- Adjusted EBITDA loss was $296M in 2025 vs. $154M loss in 2024
- 2026 guidance projects Adjusted EBITDA breakeven at midpoint
- Medical margin guidance for 2026 is $300-350M vs. $57M loss in 2025
- Company reduced operating expenses by $35M for 2026
Financial Impact
2025 revenue down $128M, gross profit down $165M, Adjusted EBITDA loss up $142M; 2026 guidance projects breakeven Adjusted EBITDA
Segment Breakdown
| Segment | Revenue |
|---|---|
| Medicare Advantage | $5.9B |
| ACO Model | $1.7B |
Risk Factors
- Failure to achieve projected breakeven Adjusted EBITDA in 2026
- Continued elevated medical cost trends at 7.5% gross
- Execution risk on portfolio optimization and cost reduction initiatives
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-011630 |
| Exhibit: ex-9922025q4.htm | 0001628280-26-011630 |
| Document: agl-20260225.htm | 0001628280-26-011630 |
| Document: 0001628280-26-011630-index-headers.html | 0001628280-26-011630 |
| Document: 0001628280-26-011630-index.html | 0001628280-26-011630 |
| Document: 0001628280-26-011630.txt | 0001628280-26-011630 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Apr 27, 2026 22w ago | DEFA14A | $27.90 $100.27 | ▲ +259.39% | ▲ +255.40% | $84.63 (+203.33%) |
Apr 27, 2026 22w ago | 8-K | $27.90 $100.27 | ▲ +259.39% | ▲ +255.40% | $84.63 (+203.33%) |
Feb 28, 2026 30w ago | Institutional Cluster | $15.40 $85.27 | ▲ +453.70% | ▲ +444.37% | $84.63 (+449.55%) |
Feb 25, 2026 31w ago | 8-K | $12.50 $80.94 | ▲ +547.52% | ▲ +540.57% | $84.63 (+577.04%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access